|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.595 USD | +2.17% |
|
+4.40% | +34.54% |
| 06/05 | Sector Update: Health Care Stocks Higher in Late Afternoon Trading | MT |
| 06/05 | Lyell Immunopharma Shares Rise After Q1 Net Loss Narrows | MT |
Lyell Immunopharma, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 84.68 million compared to USD 10.65 million a year ago. Net loss was USD 183.12 million compared to USD 250.22 million a year ago.
Basic loss per share from continuing operations was USD 0.74 compared to USD 1.84 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +34.54% | 648M | |
| +7.42% | 111B | |
| +11.21% | 106B | |
| -12.66% | 22.24B | |
| +0.44% | 21.25B | |
| -4.18% | 18.97B | |
| -37.85% | 18.52B | |
| -8.77% | 16.81B | |
| +37.38% | 12.54B | |
| -24.05% | 8.09B |
LYELL IMMUNOPHARMA, INC. 